JPS6236036B2 - - Google Patents

Info

Publication number
JPS6236036B2
JPS6236036B2 JP55137023A JP13702380A JPS6236036B2 JP S6236036 B2 JPS6236036 B2 JP S6236036B2 JP 55137023 A JP55137023 A JP 55137023A JP 13702380 A JP13702380 A JP 13702380A JP S6236036 B2 JPS6236036 B2 JP S6236036B2
Authority
JP
Japan
Prior art keywords
acid
compound
substituted
yield
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55137023A
Other languages
Japanese (ja)
Other versions
JPS5759897A (en
Inventor
Shigeru Torii
Kenji Uneyama
Hideo Tanaka
Junzo Nogami
Norio Saito
Takashi Shiroi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Chemical Co Ltd
Original Assignee
Otsuka Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Chemical Co Ltd filed Critical Otsuka Chemical Co Ltd
Priority to JP55137023A priority Critical patent/JPS5759897A/en
Publication of JPS5759897A publication Critical patent/JPS5759897A/en
Publication of JPS6236036B2 publication Critical patent/JPS6236036B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は新規なチアゾリンアゼチジノン化合
物、更に詳しくは一般式 (Rは水素、アルキル、ハロゲンで置換された
アルキル、置換若しくは非置換のフエニル基によ
り置換されたメチル若しくはハロゲン置換メチル
又はトリアルキルシリル、ZはO又はCl2を示
す)で表わされるチアゾリンアゼチジノン化合物
に関する。 本発明の化合物はβ−ラクタム系抗生物質の合
成中間体として有用である。 本発明の化合物は一般式 (式中R及びZは上記に同じ)で表わされる化
合物を水−有機溶媒混合系の均一又は不均一溶媒
中、ハロゲン酸及びハロゲン酸の1種以上の存在
下に電解反応を行うことにより得られる。 ハロゲン化の試みは種々行われているが、例え
ばR.D.G.Cooper J.A.C.S.92 2575(1970)、特
開昭52−100490号、テトラヘドロンレター781
(1980)に見られるように非常に収率が低く、そ
の他の問題点も有し満足される報告を見ない。 本発明の化合物は上記従来の方法とは異なる製
法により合成され、また文献等に未載の新規化合
物である。 本発明の出発原料である化合物(2)はペニシリン
誘導体から既報の方法、例えば前記J.A.C.S.92
2575(1970)に従い容易に合成される。 一般式(1)のRにおいてアルキルとしては例えば
メチル、エチル、ブチル、ヘキシル等を、ハロゲ
ンとしては塩素、臭素、沃素等を、置換フエニル
基としてはアルキル、アルコキシ、ハロゲン、ニ
トロ基等で置換されたフエニル等を、トリアルキ
ルシリルとしてはトリメチルシリル、トリエチル
シリル、ジメチルモノブチルシリル、モノメチル
ジブチルシリル等を例示することができる。 また本発明においてはRが置換若しくは非置換
のフエニル基により置換されたメチル基であつ
て、このような基を有する化合物(2)を本発明の電
解反応に供した場合、メチル基を構成する水素も
ハロゲン化されることがある。具体例で示せば後
記実施例5に見られるようにRが−CH(C6H52
である場合、この基は本発明の電解反応により−
CCl(C6H52に変換する。本発明は斯かる場合に
得られる化合物をも包含するものである。 本発明の電解反応において用いられる有機溶媒
としては例えば酢酸メチル、酢酸エチル、酢酸ブ
チル、ギ酸メチル、ギ酸エチル、プロピオン酸エ
チルなどのカルボン酸エステル類、ジエチルエー
テル、ジブチルエーテル、テトラヒドロフラン、
ジオキサン、エチレン、グリコールジメチルエー
テルなどのエーテル類、ジクロロメタン、クロロ
ホルム、四塩化炭素、ジブロムエタンなどのハロ
ゲン化炭化水素類、アセトニトリル、ブチロニト
リルなどのニトリル類、メタノール、エタノー
ル、イソプロパノール、ブタノール、第三級ブタ
ノールなどのアルコール類、ペンタン、ヘキサ
ン、シクロヘキサンなどの炭化水素類、ベンゼ
ン、トルエン、キシレン、クロルベンゼンなどの
芳香族化合物などの中から一つあるいは二つ以上
選ばれる。 また支持電解質として添加するハロゲン塩とし
ては、例えば塩化ナトリウム、塩化カリウム、塩
化リチウムなどのアルカリ金属塩あるいは塩化マ
グネシウム、塩化バリウム、塩化カルシウムなど
のアルカリ土類金属塩、塩化アンモニウム、塩化
テトラメチルアンモニウム、塩化テトラエチルア
ンモニウム、塩化テトラブチルアンモニウムなど
のハロゲン化アンモニウムおよび第四級アンモニ
ウム塩などがあげられる。 ハロゲン酸としては塩酸が使用される。さらに
上述のハロゲン塩又はハロゲン酸を使用する時に
同時にハロゲン酸以外の鉱酸あるいは有機酸を加
えてもよい。添加される鉱酸としては硫酸、硝
酸、炭酸、硫酸水素カリウム、硫酸水素ナトリウ
ム、リン酸などがあげられる。又有機酸としては
ギ酸、酢酸、プロピオン酸、酪酸、洒石酸、シユ
ウ酸、クエン酸、フタル酸、リンゴ酸、パラトル
エンスルホン酸などがあげられる。 本発明の電解反応は約5〜500mA/cm3の範囲
の電流密度で行なえるが好ましくは約10〜
50mA/cm3の範囲である。また電極は通常電解反
応に使用される白金、炭素、ステンレス、酸化
鉛、ニツケルなどが使用できる。電解は約−20〜
100℃の範囲の温度で行なえるが好ましくは約−
10〜50℃で行なうとよい。電解反応を行う場合隔
膜を用いても無隔膜でもよい。 本電解反応に必要な通電量は、電解槽の形状、
電極の種類、基質濃度、基質の反応性等により一
定しないが、約2〜50F/molの電気量を通電す
ることにより85〜95%の高収率で目的物がほぼ純
品として得られる。 本発明においてハロゲン化反応は電解と同一反
応槽内で同時に行うことも電解槽とハロゲン化反
応容器を別々にして反応を行うことも出来る。 実施例 1 出発原料としての上記2−(3−ベンゾイル−
7−オキソ−4−チオ−2,6−ジアザビシクロ
〔3.2.0〕ヘプト−2−エン−6−イル)3−メチ
ル−3−ブテン酸メチル50mg、濃硫酸0.07ml、塩
化メチレン5ml、塩化ナトリウム1gを水3mlに
溶解した溶液を反応容器に入れ、3cm2の白金電極
を装入し、30mA、1.6〜1.8V、25℃で2時間電解
を行う。電解終了後、塩化メチレン30mlで抽出
し、抽出液を亜硫酸ナトリウム水、重曹水、食塩
水で洗浄する。無水硫酸ナトリウムで乾燥し、溶
媒を除去すると淡黄色液体74mgを得る。これをシ
リカゲルカラムを用い酢酸エチレン−ベンゼンで
展開すると目的化合物51mg(収率93%)を得る。 IR 1780,1745,1660,1600,858cm-1 NMR(CDCl3) 3.79(3H s COOCH3) 4.16(2H s −CH2Cl) 5.23(2H d J=4Hz C=CH2) 5.55(1H s CH−COOCH3) 5.96(1H d J=4Hz −CH) 6.37(1H d J=4Hz −CH) 7.4〜8.4(5H m フエニル) 実施例 2 上記反応を原料50mgを用いて実施例1と同様に
して行つたところ、目的物を50.5mg(収率93.5
%)得た。 NMR(CDCl3) 4.89(2H s −CH2CCl3) 4.16(2H s −CH2Cl) 5.23(2H d C=CH2) 5.55(1H s CH−COOCH2CCl3) 実施例 3 塩化ナトリウム1gを3mlの水に溶解し、上記
原料化合物50mg、濃硫酸0.07ml、塩化メチレン5
mlを反応容器に入れ、実施例1と同様の操作によ
り目的物51.8mg(収率95%)を得た。 NMR(CDCl3) 1.38(9H s COO−t−Bu) 3.81(2H s CH2Cl) 5.14(2H s C=CH2) 5.41(1H s CHCOO−t−Bu) 7.3〜7.9(5H m フエニル) 実施例 4 上記原料化合物50mgを用いて、実施例1と同様
の操作処理を行うと目的物49.8mg(収率90.2%)
を得る。 IR 1715cm-1 NMR(CDCl3) 4.18(2H s CH2Cl) 5.22(2H d C=CH2) 5.95(1H d CH) 6.39(1H d CH) 7.4〜8.3(5H m フエニル) 実施例 5 上記原料化合物50mgを用いて実施例1と同様の
操作処理を行うと目的物51.8mg(収率91%)を得
る。IR,NMRより目的物を確認した。 実施例 6 上記原料化合物50mgを用いて実施例1と同様の
操作処理を行うと目的物49.8mg(収率92.8%)を
得る。 NMR(CDCl3) 5.05(2H s
The present invention relates to novel thiazoline azetidinone compounds, more specifically, the general formula (R is hydrogen, alkyl, alkyl substituted with halogen, methyl substituted with substituted or unsubstituted phenyl group, methyl substituted with halogen, or trialkylsilyl, Z is O or Cl 2 ) Thiazoline azetidinone Regarding compounds. The compounds of the present invention are useful as synthetic intermediates for β-lactam antibiotics. The compounds of the present invention have the general formula (wherein R and Z are the same as above) can be obtained by electrolytically reacting the compound represented by the formula (in which R and Z are the same as above) in a homogeneous or heterogeneous water-organic solvent mixed solvent in the presence of a halogen acid and one or more halogen acids. It will be done. Various attempts at halogenation have been made, including RDGCooper JACS 92 2575 (1970), Japanese Patent Application Laid-open No. 100490/1983, and Tetrahedron Letter 781.
(1980), the yield is very low, and there are other problems as well, and no satisfactory reports have been found. The compound of the present invention was synthesized by a manufacturing method different from the conventional method described above, and is a new compound that has not been described in any literature. Compound (2), which is the starting material of the present invention, can be prepared from a penicillin derivative by a previously reported method, such as the above-mentioned JACS 92 ,
2575 (1970). In R of general formula (1), alkyl is substituted with methyl, ethyl, butyl, hexyl, etc., halogen is substituted with chlorine, bromine, iodine, etc., and substituted phenyl group is substituted with alkyl, alkoxy, halogen, nitro group, etc. Examples of the trialkylsilyl include trimethylsilyl, triethylsilyl, dimethylmonobutylsilyl, and monomethyldibutylsilyl. In addition, in the present invention, R is a methyl group substituted with a substituted or unsubstituted phenyl group, and when the compound (2) having such a group is subjected to the electrolytic reaction of the present invention, a methyl group is formed. Hydrogen may also be halogenated. To give a specific example, as shown in Example 5 below, R is -CH(C 6 H 5 ) 2
, this group is converted into − by the electrolytic reaction of the present invention.
Convert to CCl( C6H5 ) 2 . The present invention also includes compounds obtained in such cases. Examples of organic solvents used in the electrolytic reaction of the present invention include carboxylic acid esters such as methyl acetate, ethyl acetate, butyl acetate, methyl formate, ethyl formate, and ethyl propionate, diethyl ether, dibutyl ether, tetrahydrofuran,
Ethers such as dioxane, ethylene, glycol dimethyl ether, halogenated hydrocarbons such as dichloromethane, chloroform, carbon tetrachloride, dibromoethane, nitriles such as acetonitrile, butyronitrile, methanol, ethanol, isopropanol, butanol, tertiary butanol, etc. One or more are selected from alcohols, hydrocarbons such as pentane, hexane, and cyclohexane, and aromatic compounds such as benzene, toluene, xylene, and chlorobenzene. Examples of the halogen salt added as a supporting electrolyte include alkali metal salts such as sodium chloride, potassium chloride, and lithium chloride, alkaline earth metal salts such as magnesium chloride, barium chloride, and calcium chloride, ammonium chloride, tetramethylammonium chloride, Examples include ammonium halides and quaternary ammonium salts such as tetraethylammonium chloride and tetrabutylammonium chloride. Hydrochloric acid is used as the halogen acid. Furthermore, when using the above-mentioned halogen salt or halogen acid, a mineral acid or organic acid other than the halogen acid may be added at the same time. Examples of the mineral acids to be added include sulfuric acid, nitric acid, carbonic acid, potassium hydrogen sulfate, sodium hydrogen sulfate, and phosphoric acid. Examples of organic acids include formic acid, acetic acid, propionic acid, butyric acid, acetic acid, oxalic acid, citric acid, phthalic acid, malic acid, and paratoluenesulfonic acid. The electrolytic reaction of the present invention can be carried out at a current density in the range of about 5 to 500 mA/cm 3 , preferably about 10 to 500 mA/cm 3 .
It is in the range of 50mA/ cm3 . Further, the electrodes can be made of platinum, carbon, stainless steel, lead oxide, nickel, etc., which are commonly used in electrolytic reactions. Electrolysis is about −20~
It can be carried out at temperatures in the range of 100°C, but preferably about -
It is best to do this at a temperature of 10 to 50°C. When carrying out an electrolytic reaction, a diaphragm may be used or no diaphragm may be used. The amount of current required for this electrolytic reaction depends on the shape of the electrolytic cell,
Although it varies depending on the type of electrode, substrate concentration, substrate reactivity, etc., the target product can be obtained as an almost pure product with a high yield of 85 to 95% by applying electricity with an amount of electricity of about 2 to 50 F/mol. In the present invention, the halogenation reaction can be carried out simultaneously with the electrolysis in the same reaction vessel, or the reaction can be carried out in separate electrolytic vessels and halogenation reaction vessels. Example 1 The above 2-(3-benzoyl-
Methyl 7-oxo-4-thio-2,6-diazabicyclo[3.2.0]hept-2-en-6-yl)3-methyl-3-butenoate 50 mg, concentrated sulfuric acid 0.07 ml, methylene chloride 5 ml, sodium chloride A solution of 1 g dissolved in 3 ml of water is placed in a reaction vessel, a 3 cm 2 platinum electrode is inserted, and electrolysis is performed at 30 mA, 1.6 to 1.8 V, and 25°C for 2 hours. After the electrolysis is completed, extract with 30 ml of methylene chloride, and wash the extract with sodium sulfite solution, sodium bicarbonate solution, and saline solution. Dry over anhydrous sodium sulfate and remove the solvent to obtain 74 mg of a pale yellow liquid. This was developed with ethylene acetate-benzene using a silica gel column to obtain 51 mg (yield 93%) of the target compound. IR 1780, 1745, 1660, 1600, 858 cm -1 NMR (CDCl 3 ) 3.79 (3H s COOCH 3 ) 4.16 (2H s - CH 2 Cl) 5.23 (2H d J=4Hz C=CH 2 ) 5.55 (1H s CH -COOCH 3 ) 5.96 (1H d J = 4Hz -CH) 6.37 (1H d J = 4Hz -CH) 7.4 - 8.4 (5H m phenyl) Example 2 When the above reaction was carried out in the same manner as in Example 1 using 50 mg of raw material, 50.5 mg of the target product (yield 93.5
%)Obtained. NMR (CDCl 3 ) 4.89 (2H s - CH 2 CCl 3 ) 4.16 (2H s - CH 2 Cl) 5.23 (2H d C=CH 2 ) 5.55 (1H s CH-COOCH 2 CCl 3 ) Example 3 Dissolve 1 g of sodium chloride in 3 ml of water, add 50 mg of the above raw material compound, 0.07 ml of concentrated sulfuric acid, and 5 ml of methylene chloride.
ml was placed in a reaction vessel, and the same procedure as in Example 1 was performed to obtain 51.8 mg (yield: 95%) of the target product. NMR (CDCl 3 ) 1.38 (9H s COO-t-Bu) 3.81 (2H s CH 2 Cl) 5.14 (2H s C=CH 2 ) 5.41 (1H s CHCOO-t-Bu) 7.3-7.9 (5H m phenyl) Example 4 Using 50 mg of the above raw material compound and performing the same operation as in Example 1, the target product was 49.8 mg (yield 90.2%).
get. IR 1715cm -1 NMR (CDCl 3 ) 4.18 (2H s CH 2 Cl) 5.22 (2H d C=CH 2 ) 5.95 (1H d CH) 6.39 (1H d CH) 7.4-8.3 (5H m phenyl) Example 5 When the same operation as in Example 1 is performed using 50 mg of the above raw material compound, 51.8 mg (yield 91%) of the target compound is obtained. The target product was confirmed by IR and NMR. Example 6 Using 50 mg of the above raw material compound, the same operation as in Example 1 is performed to obtain 49.8 mg (yield 92.8%) of the target compound. NMR ( CDCl3 ) 5.05 (2H s

【式】) 4.12(2H s CH2Cl) 5.25(2H d C=CH2) 7.10〜8.03(4H m フエニル) 実施例 7 2−(3−ジクロルフエニルメチル−7−オキ
ソ−4−チオ−2,6−ジアザビシクロ
〔3.2.0〕ヘプト−2−エン−6−イル)−3−ク
ロロメチル−3−ブテン酸メチルの合成 塩化ナトリウム1gを水3c.c.に溶解し、これに
濃硫酸0.07c.c.、塩化メチレン5c.c.、2−(3−ベ
ンジル−7−オキソ−4−チオ−2,6−ジアザ
ビシクロ〔3.2.0〕ヘプト−2−エン−6−イ
ル)−3−メチル−3−ブテン酸メチル50mgを加
え電解液を調製する。3cm2の白金板電極を装入し
30mA定電流、1.6〜1.8V、25℃で約2時間電解を
行う。電解終了後塩化メチレン(30ml)で抽出を
行う。抽出液は亜硫酸ナトリウム水、重ソウ水、
食塩水で洗浄後、無水硫酸ナトリウムで乾燥し、
溶媒を除去して淡黄色の液体74mgを得た。このも
のをシリカゲルカラムを用いベンゼン:酢酸エチ
ル(5:1)の混合溶媒で展開すると目的化合物
が62.5mg(収率96%)得られた。 IR 1780,1745cm-1 NMR(CDCl3) 3.75(3H s COOCH3) 3.81(2H s −CH2Cl) 5.14(2H s C=CH2) 5.41(1H s −CHCOOCH3) 6.05(2H s −CH) 7.3〜7.9(5H m フエニル) 実施例 8 NaCl1gを水5c.c.にとかし、濃硫酸0.07c.c.、酢
酸エチル5c.c.を加え、更に実施例7と同じ出発原
料50mgを加えて電解液を調製する。30mA定電
流、1.8〜1.9V、25〜27℃で2時間電解し実施例
7と同様の処理をして目的の化合物61mg(収率
93.5%)を得た。化合物の確認はIR,NMRで行
い実施例7と同様の結果を得て同定を行つた。 実施例 9 上記出発原料50mgを用いて実施例7と同様に実
験を行い、上記目的化合物を61mg(収率95%)得
た。 NMR(CDCl3) 1.38(9H s COO−t−Bu) 3.85(2H s −CH2Cl) 5.12(2H s C=CH2) 5.41(1H s −CHCOO−t−Bu) 6.03(2H s CH) 7.3〜8.0(5H m フエニル) 実施例 10 原料として上記化合物50mgを用いて実施例7と
同様の操作処理を行うと目的物56.3mgを得る。収
率91.5% NMR(CDCl3) 4.04(2H s CH2Cl) 4.75(2H s CH2CCl3) 5.18(2H s C=CH2) 5.54(1H s CHCOOCH2CCl3) 7.0〜7.65(5H m フエニル) 実施例 11 原料として上記化合物50mgを用いて実施例7と
同様の操作処理を行うと目的物59.0mgを得る。収
率88.9% IR 1715cm-1 NMR(CDCl3) 4.20(2H s CH2Cl) 5.28(2H d C=CH2) 5.92(1H d CH) 6.42(1H d CH) 7.5〜8.4(5H m フエニル) 実施例 12 上記原料化合物50mgを用いて実施例7と同様の
操作処理を行うと目的物56.2mg(収率91.5%)を
得る。 NMR(CDCl3) 4.08(2H s CH2Cl) 5.05(2H s
[Formula]) 4.12 (2H s CH 2 Cl) 5.25 (2H d C=CH 2 ) 7.10-8.03 (4H m phenyl) Example 7 Methyl 2-(3-dichlorophenylmethyl-7-oxo-4-thio-2,6-diazabicyclo[3.2.0]hept-2-en-6-yl)-3-chloromethyl-3-butenoate Synthesis Dissolve 1 g of sodium chloride in 3 c.c. of water, add 0.07 cc of concentrated sulfuric acid, 5 c.c. of methylene chloride, 2-(3-benzyl-7-oxo-4-thio-2,6-diazabicyclo[3.2 .0] Add 50 mg of methyl hept-2-en-6-yl)-3-methyl-3-butenoate to prepare an electrolytic solution. Insert a 3 cm 2 platinum plate electrode.
Electrolyze at 30 mA constant current, 1.6 to 1.8 V, and 25°C for about 2 hours. After the electrolysis is complete, extract with methylene chloride (30ml). Extract liquid is sodium sulfite water, hydrogenated sodium water,
After washing with saline, drying with anhydrous sodium sulfate,
Removal of the solvent gave 74 mg of a pale yellow liquid. This product was developed using a silica gel column with a mixed solvent of benzene:ethyl acetate (5:1) to obtain 62.5 mg (yield: 96%) of the target compound. IR 1780, 1745cm -1 NMR (CDCl 3 ) 3.75 (3H s COOCH 3 ) 3.81 (2H s -CH 2 Cl) 5.14 (2H s C=CH 2 ) 5.41 (1H s -CHCOOCH 3 ) 6.05 (2H s -CH ) 7.3-7.9 (5H m phenyl) Example 8 Dissolve 1 g of NaCl in 5 c.c. of water, add 0.07 cc of concentrated sulfuric acid and 5 c.c. of ethyl acetate, and then add 50 mg of the same starting material as in Example 7 to prepare an electrolytic solution. Prepare. Electrolysis was carried out at 30mA constant current, 1.8-1.9V, 25-27℃ for 2 hours, and the same treatment as in Example 7 was carried out to obtain 61mg of the target compound (yield:
93.5%). The compound was confirmed by IR and NMR, and the same results as in Example 7 were obtained, and the compound was identified. Example 9 An experiment was conducted in the same manner as in Example 7 using 50 mg of the above starting material, and 61 mg (yield 95%) of the above target compound was obtained. NMR (CDCl 3 ) 1.38 (9H s COO-t-Bu) 3.85 (2H s -CH 2 Cl) 5.12 (2H s C=CH 2 ) 5.41 (1H s -CHCOO-t-Bu) 6.03 (2H s CH) 7.3-8.0 (5H m phenyl) Example 10 Using 50 mg of the above compound as a raw material, the same operation as in Example 7 is carried out to obtain 56.3 mg of the target product. Yield 91.5% NMR (CDCl 3 ) 4.04 (2H s CH 2 Cl) 4.75 (2H s CH 2 CCl 3 ) 5.18 (2H s C=CH 2 ) 5.54 (1H s CHCOOCH 2 CCl 3 ) 7.0-7.65 (5H m phenyl) Example 11 Using 50 mg of the above compound as a raw material, the same operation as in Example 7 is performed to obtain 59.0 mg of the target product. Yield 88.9% IR 1715cm -1 NMR (CDCl 3 ) 4.20 (2H s CH 2 Cl) 5.28 (2H d C=CH 2 ) 5.92 (1H d CH) 6.42 (1H d CH) 7.5-8.4 (5H m phenyl) Example 12 When the same operation as in Example 7 is performed using 50 mg of the above raw material compound, 56.2 mg (yield 91.5%) of the target compound is obtained. NMR (CDCl 3 ) 4.08 (2H s CH 2 Cl) 5.05 (2H s

【式】) 5.23(2H d C=CH2) 7.10〜8.05(4H m フエニル)[Formula]) 5.23 (2H d C=CH 2 ) 7.10-8.05 (4H m phenyl)

Claims (1)

【特許請求の範囲】 1 一般式 (Rは水素、アルキル、ハロゲンで置換された
アルキル、置換若しくは非置換のフエニル基によ
り置換されたメチル若しくはハロゲン置換メチル
又はトリアルキルシリル、ZはO又はCl2を示
す)で表わされるチアゾリンアゼチジノン化合
物。
[Claims] 1. General formula (R is hydrogen, alkyl, alkyl substituted with halogen, methyl substituted with substituted or unsubstituted phenyl group, methyl substituted with halogen, or trialkylsilyl, Z is O or Cl 2 ) Thiazoline azetidinone Compound.
JP55137023A 1980-09-30 1980-09-30 Thiazolineazatidinone Granted JPS5759897A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP55137023A JPS5759897A (en) 1980-09-30 1980-09-30 Thiazolineazatidinone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55137023A JPS5759897A (en) 1980-09-30 1980-09-30 Thiazolineazatidinone

Publications (2)

Publication Number Publication Date
JPS5759897A JPS5759897A (en) 1982-04-10
JPS6236036B2 true JPS6236036B2 (en) 1987-08-05

Family

ID=15189025

Family Applications (1)

Application Number Title Priority Date Filing Date
JP55137023A Granted JPS5759897A (en) 1980-09-30 1980-09-30 Thiazolineazatidinone

Country Status (1)

Country Link
JP (1) JPS5759897A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5955888A (en) * 1982-09-24 1984-03-31 Otsuka Chem Co Ltd Azetidinone compound
US5222471A (en) * 1992-09-18 1993-06-29 Kohler Co. Emission control system for an internal combustion engine

Also Published As

Publication number Publication date
JPS5759897A (en) 1982-04-10

Similar Documents

Publication Publication Date Title
EP0118567B1 (en) Process for the preparationof 2-substituted cephem derivatives
US4603014A (en) Thiazolinoazetidinone derivatives and process for the preparation of the same
JP2005536558A (en) Process for the production of nitrooxy derivatives of naproxen
JPS6236036B2 (en)
US4499265A (en) Process for preparing 3-exo-methylenecepham derivatives
US4532077A (en) Thiazolineazetidinone-type compounds
JP3091006B2 (en) Synthesis of 1,2,3-oxathiazolidine derivatives and thieno [3,2-c] pyridine derivatives
JPS6221072B2 (en)
US4009172A (en) 2,3,3A,6,7,7A-Hexahydro-thieno[3,2-b]pyridin-(4H)5-ones
JPH0561355B2 (en)
JPH0459310B2 (en)
US20040002600A1 (en) Process for the conversion of penam ring system to cepham ring system
JPS6236037B2 (en)
JPH0154435B2 (en)
JP4159784B2 (en) Method for producing 2,3-disubstituted thiophene derivatives
WO1997034027A1 (en) Process for the preparation of 3-alkoxymethylcephems
JP2612443B2 (en) Method for producing 2β-substituted methylpenicillin derivative
JPH09249984A (en) Method for producing optically active epoxide derivative
JPS6056693B2 (en) Method for producing halogenated propionic acid derivatives
JPS6236038B2 (en)
SU565633A3 (en) Method for obtaining 3-fluorcephalosporines
JP2006213617A (en) Acetylene aldehyde and method for producing the same, acetylene aldehyde acetal and method for producing the same
JPH1180164A (en) Production of 3-dialkoxymethyl cephem compound
JPS6024187B2 (en) Method for producing β-lactam derivatives
JPS59164771A (en) Preparation of chlorinated azetidinone derivative